FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 2120447 · Received June 10, 2011

Report

Report Number
2024168-2011-04112
Event Type
Injury
Date Received
June 10, 2011
Date of Event
February 14, 2011
Report Date
May 16, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THERE WAS NO REPORTED PRODUCT DEFICIENCY. THE REPORTED PATIENT EFFECTS OF ANGINA AND RESTENOSIS, AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE ARE KNOWN ADVERSE EVENTS ASSOCIATED WITH CORONARY STENTING PROCEDURES. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING.

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. THE DEVICE REMAINS IN THE PATIENT. THE LOT NUMBER WAS PROVIDED. A FOLLOW-UP REPORT WILL BE SUBMITTED WITH ALL RELEVANT INFORMATION.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD A 2.75 X 28 MM XIENCE STENT IMPLANTED ON (B)(6) 2010. THE PATIENT RETURNED ON (B)(6) 2011 AND RESTENOSIS WAS NOTED IN THE XIENCE V STENT. THE PATIENT DECLINED TO HAVE A BYPASS SURGERY AND WAS TREATED WITH MEDICATIONS. AS OF (B)(6) 2011, THE PATIENT WAS STILL EXPERIENCING CHEST PAIN AND THE PHYSICIAN ADAPTED THE MEDICAL TREATMENT, ADDING MEDICATIONS FOR THE CHEST PAIN. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 9090441

Patients

Seq Age Sex Outcome Treatment
1 73 YR Hospitalization| R